A therapeutic strategy for the treatment of cancer could be idealised on targeting the PITPNA-AS1-associated signalling, which mediates the effects of c-MET on the proliferation, apoptosis and cell cycle in cervical cancer cells [86]. The gene discussed is MET; the disease is cervical carcinoma.